Oral Anti-allergic Drugs - Global and China Top Players Market Share and Ranking 2023
According to the research report, the global market for Oral Anti-allergic Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Oral Anti-allergic Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Oral Anti-allergic Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital Pharmacies grew percent to account for percent of the total market sales, and Retail Pharmacies grew percent.
This report studies and analyses global Oral Anti-allergic Drugs status and future trends, helps the client to determine the Oral Anti-allergic Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Oral Anti-allergic Drugs, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Oral Anti-allergic Drugs market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Oral Anti-allergic Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Oral Anti-allergic Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Oral Anti-allergic Drugs key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Oral Anti-allergic Drugs key producing regions, capacity, production, and year over year growth
(6) Oral Anti-allergic Drugs industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Sanofi
Johnson & Johnson
Merck
Teva
GlaxoSmithKline
Bayer
Almirall
Pfizer
AstraZeneca
Sun Pharma
Novartis
Boehringer Ingelheim
UCB Pharma
Yangtze River Pharmaceutical Group
Hainan Poly Pharm
Chongqing Huapont Pharmaceutical
Dawnrays Pharma
Market segment by Type, covers
Antihistamine Drugs
Allergic Mediator Release Agent
Immunosuppressant Drugs
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Oral Anti-allergic Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Oral Anti-allergic Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Oral Anti-allergic Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Oral Anti-allergic Drugs, percent & CAGR, 2018-2029
Chapter 5: Oral Anti-allergic Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Oral Anti-allergic Drugs Definition
1.2 Global Oral Anti-allergic Drugs Market Size and Forecast
1.2.1 By Consumption Value, Global Oral Anti-allergic Drugs Market Size，2018-2029
1.2.2 By Sales Quantity, Global Oral Anti-allergic Drugs Market Size，2018-2029
1.2.3 Global Oral Anti-allergic Drugs Average Selling Price (ASP)，2018-2029
1.3 China Oral Anti-allergic Drugs Market Size and Forecast
1.3.1 By Consumption Value, China Oral Anti-allergic Drugs Market Size，2018-2029
1.3.2 By Sales Quantity, China Oral Anti-allergic Drugs Market Size，2018-2029
1.3.3 China Oral Anti-allergic Drugs Average Selling Price (ASP)， 2018-2029
1.4 Share of China Oral Anti-allergic Drugs Market with Respect to the Global Market
1.4.1 By Consumption Value, China Oral Anti-allergic Drugs Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Oral Anti-allergic Drugs Market Share in Global, 2018-2029
1.4.3 Oral Anti-allergic Drugs Market Size: China VS Global, 2018-2029
1.5 Oral Anti-allergic Drugs Market Dynamics
1.5.1 Oral Anti-allergic Drugs Market Drivers
1.5.2 Oral Anti-allergic Drugs Market Restraints
1.5.3 Oral Anti-allergic Drugs Industry Trends
1.5.4 Oral Anti-allergic Drugs Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Oral Anti-allergic Drugs, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Oral Anti-allergic Drugs, Global Market Share by Company, 2018-2023
2.3 Oral Anti-allergic Drugs Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Oral Anti-allergic Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Oral Anti-allergic Drugs Concentration Ratio
2.6 Global Oral Anti-allergic Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Oral Anti-allergic Drugs Manufacturers Product Type
2.8 Head Office and Oral Anti-allergic Drugs Production Site of Key Manufacturer
2.9 Oral Anti-allergic Drugs Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Oral Anti-allergic Drugs, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Oral Anti-allergic Drugs, China Market Share by Company, 2018-2023
3.3 China Oral Anti-allergic Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Oral Anti-allergic Drugs Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Oral Anti-allergic Drugs Capacity by Region
4.3 Global Oral Anti-allergic Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Oral Anti-allergic Drugs Production by Region, 2018-2029
4.5 Global Oral Anti-allergic Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Oral Anti-allergic Drugs Industry Chain
5.2 Oral Anti-allergic Drugs Upstream Analysis
5.2.1 Oral Anti-allergic Drugs Core Raw Materials
5.2.2 Main Manufacturers of Oral Anti-allergic Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Oral Anti-allergic Drugs Production Mode
5.6 Oral Anti-allergic Drugs Procurement Model
5.7 Oral Anti-allergic Drugs Industry Sales Model and Sales Channels
5.7.1 Oral Anti-allergic Drugs Sales Model
5.7.2 Oral Anti-allergic Drugs Typical Distributors
6 Sights by Type
6.1 Oral Anti-allergic Drugs Classification
6.1.1 Antihistamine Drugs
6.1.2 Allergic Mediator Release Agent
6.1.3 Immunosuppressant Drugs
6.2 By Type, Global Oral Anti-allergic Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Oral Anti-allergic Drugs Consumption Value, 2018-2029
6.4 By Type, Global Oral Anti-allergic Drugs Sales Quantity, 2018-2029
6.5 By Type, Global Oral Anti-allergic Drugs Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Oral Anti-allergic Drugs Segment by Application
7.1.1 Hospital Pharmacies
7.1.2 Retail Pharmacies
7.1.3 Online Pharmacies
7.2 By Application, Global Oral Anti-allergic Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Oral Anti-allergic Drugs Consumption Value, 2018-2029
7.4 By Application, Global Oral Anti-allergic Drugs Sales Quantity, 2018-2029
7.5 By Application, Global Oral Anti-allergic Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Oral Anti-allergic Drugs Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Oral Anti-allergic Drugs Consumption Value, 2018-2029
8.3 By Region, Global Oral Anti-allergic Drugs Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Oral Anti-allergic Drugs & Forecasts, 2018-2029
8.4.2 By Country, North America Oral Anti-allergic Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Oral Anti-allergic Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Oral Anti-allergic Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Oral Anti-allergic Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Oral Anti-allergic Drugs Market Size Market Share
8.7 South America
8.7.1 South America Oral Anti-allergic Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Oral Anti-allergic Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Oral Anti-allergic Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Oral Anti-allergic Drugs Consumption Value, 2018-2029
9.3 By Country, Global Oral Anti-allergic Drugs Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Oral Anti-allergic Drugs Market Size, 2018-2029
9.4.2 By Type, U.S. Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Oral Anti-allergic Drugs Market Size, 2018-2029
9.5.2 By Type, Europe Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Oral Anti-allergic Drugs Market Size, 2018-2029
9.6.2 By Type, China Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Oral Anti-allergic Drugs Market Size, 2018-2029
9.7.2 By Type, Japan Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Oral Anti-allergic Drugs Market Size, 2018-2029
9.8.2 By Type, South Korea Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Oral Anti-allergic Drugs Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Oral Anti-allergic Drugs Market Size, 2018-2029
9.10.2 By Type, India Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Oral Anti-allergic Drugs Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Sanofi
10.1.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.1.2 Sanofi Oral Anti-allergic Drugs Models, Specifications, and Application
10.1.3 Sanofi Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Sanofi Company Profile and Main Business
10.1.5 Sanofi Recent Developments
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
10.2.2 Johnson & Johnson Oral Anti-allergic Drugs Models, Specifications, and Application
10.2.3 Johnson & Johnson Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Johnson & Johnson Company Profile and Main Business
10.2.5 Johnson & Johnson Recent Developments
10.3 Merck
10.3.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.3.2 Merck Oral Anti-allergic Drugs Models, Specifications, and Application
10.3.3 Merck Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Merck Company Profile and Main Business
10.3.5 Merck Recent Developments
10.4 Teva
10.4.1 Teva Company Information, Head Office, Market Area, and Industry Position
10.4.2 Teva Oral Anti-allergic Drugs Models, Specifications, and Application
10.4.3 Teva Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Teva Company Profile and Main Business
10.4.5 Teva Recent Developments
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Information, Head Office, Market Area, and Industry Position
10.5.2 GlaxoSmithKline Oral Anti-allergic Drugs Models, Specifications, and Application
10.5.3 GlaxoSmithKline Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 GlaxoSmithKline Company Profile and Main Business
10.5.5 GlaxoSmithKline Recent Developments
10.6 Bayer
10.6.1 Bayer Company Information, Head Office, Market Area, and Industry Position
10.6.2 Bayer Oral Anti-allergic Drugs Models, Specifications, and Application
10.6.3 Bayer Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Bayer Company Profile and Main Business
10.6.5 Bayer Recent Developments
10.7 Almirall
10.7.1 Almirall Company Information, Head Office, Market Area, and Industry Position
10.7.2 Almirall Oral Anti-allergic Drugs Models, Specifications, and Application
10.7.3 Almirall Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Almirall Company Profile and Main Business
10.7.5 Almirall Recent Developments
10.8 Pfizer
10.8.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.8.2 Pfizer Oral Anti-allergic Drugs Models, Specifications, and Application
10.8.3 Pfizer Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Pfizer Company Profile and Main Business
10.8.5 Pfizer Recent Developments
10.9 AstraZeneca
10.9.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.9.2 AstraZeneca Oral Anti-allergic Drugs Models, Specifications, and Application
10.9.3 AstraZeneca Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 AstraZeneca Company Profile and Main Business
10.9.5 AstraZeneca Recent Developments
10.10 Sun Pharma
10.10.1 Sun Pharma Company Information, Head Office, Market Area, and Industry Position
10.10.2 Sun Pharma Oral Anti-allergic Drugs Models, Specifications, and Application
10.10.3 Sun Pharma Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Sun Pharma Company Profile and Main Business
10.10.5 Sun Pharma Recent Developments
10.11 Novartis
10.11.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.11.2 Novartis Oral Anti-allergic Drugs Models, Specifications, and Application
10.11.3 Novartis Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Novartis Company Profile and Main Business
10.11.5 Novartis Recent Developments
10.12 Boehringer Ingelheim
10.12.1 Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
10.12.2 Boehringer Ingelheim Oral Anti-allergic Drugs Models, Specifications, and Application
10.12.3 Boehringer Ingelheim Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Boehringer Ingelheim Company Profile and Main Business
10.12.5 Boehringer Ingelheim Recent Developments
10.13 UCB Pharma
10.13.1 UCB Pharma Company Information, Head Office, Market Area, and Industry Position
10.13.2 UCB Pharma Oral Anti-allergic Drugs Models, Specifications, and Application
10.13.3 UCB Pharma Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 UCB Pharma Company Profile and Main Business
10.13.5 UCB Pharma Recent Developments
10.14 Yangtze River Pharmaceutical Group
10.14.1 Yangtze River Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position
10.14.2 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Models, Specifications, and Application
10.14.3 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Yangtze River Pharmaceutical Group Company Profile and Main Business
10.14.5 Yangtze River Pharmaceutical Group Recent Developments
10.15 Hainan Poly Pharm
10.15.1 Hainan Poly Pharm Company Information, Head Office, Market Area, and Industry Position
10.15.2 Hainan Poly Pharm Oral Anti-allergic Drugs Models, Specifications, and Application
10.15.3 Hainan Poly Pharm Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Hainan Poly Pharm Company Profile and Main Business
10.15.5 Hainan Poly Pharm Recent Developments
10.16 Chongqing Huapont Pharmaceutical
10.16.1 Chongqing Huapont Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.16.2 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Models, Specifications, and Application
10.16.3 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Chongqing Huapont Pharmaceutical Company Profile and Main Business
10.16.5 Chongqing Huapont Pharmaceutical Recent Developments
10.17 Dawnrays Pharma
10.17.1 Dawnrays Pharma Company Information, Head Office, Market Area, and Industry Position
10.17.2 Dawnrays Pharma Oral Anti-allergic Drugs Models, Specifications, and Application
10.17.3 Dawnrays Pharma Oral Anti-allergic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Dawnrays Pharma Company Profile and Main Business
10.17.5 Dawnrays Pharma Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Oral Anti-allergic Drugs Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Oral Anti-allergic Drugs Market Restraints
Table 3. Oral Anti-allergic Drugs Market Trends
Table 4. Oral Anti-allergic Drugs Industry Policy
Table 5. Global Oral Anti-allergic Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Oral Anti-allergic Drugs Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Oral Anti-allergic Drugs Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Oral Anti-allergic Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Oral Anti-allergic Drugs Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Oral Anti-allergic Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Oral Anti-allergic Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Oral Anti-allergic Drugs Manufacturers Product Type
Table 13. Head Office and Oral Anti-allergic Drugs Production Site of Key Manufacturer
Table 14. Oral Anti-allergic Drugs Capacity of Major Manufacturers and Future Plan
Table 15. China Oral Anti-allergic Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Oral Anti-allergic Drugs Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Oral Anti-allergic Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Oral Anti-allergic Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Oral Anti-allergic Drugs Production by Region, 2018-2023, (K Units)
Table 20. Global Oral Anti-allergic Drugs Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Oral Anti-allergic Drugs Upstream (Raw Materials)
Table 22. Global Oral Anti-allergic Drugs Typical Customers
Table 23. Oral Anti-allergic Drugs Typical Distributors
Table 24. By Type, Global Oral Anti-allergic Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Oral Anti-allergic Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Oral Anti-allergic Drugs Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Oral Anti-allergic Drugs Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Oral Anti-allergic Drugs Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Oral Anti-allergic Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Oral Anti-allergic Drugs Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Oral Anti-allergic Drugs Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Oral Anti-allergic Drugs Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Oral Anti-allergic Drugs Sales Quantity Market Share, 2018-2029
Table 34. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 35. Sanofi Oral Anti-allergic Drugs Models, Specifications, and Application
Table 36. Sanofi Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Sanofi Company Profile and Main Business
Table 38. Sanofi Recent Developments
Table 39. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
Table 40. Johnson & Johnson Oral Anti-allergic Drugs Models, Specifications, and Application
Table 41. Johnson & Johnson Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Johnson & Johnson Company Profile and Main Business
Table 43. Johnson & Johnson Recent Developments
Table 44. Merck Company Information, Head Office, Market Area, and Industry Position
Table 45. Merck Oral Anti-allergic Drugs Models, Specifications, and Application
Table 46. Merck Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Merck Company Profile and Main Business
Table 48. Merck Recent Developments
Table 49. Teva Company Information, Head Office, Market Area, and Industry Position
Table 50. Teva Oral Anti-allergic Drugs Models, Specifications, and Application
Table 51. Teva Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Teva Company Profile and Main Business
Table 53. Teva Recent Developments
Table 54. GlaxoSmithKline Company Information, Head Office, Market Area, and Industry Position
Table 55. GlaxoSmithKline Oral Anti-allergic Drugs Models, Specifications, and Application
Table 56. GlaxoSmithKline Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. GlaxoSmithKline Company Profile and Main Business
Table 58. GlaxoSmithKline Recent Developments
Table 59. Bayer Company Information, Head Office, Market Area, and Industry Position
Table 60. Bayer Oral Anti-allergic Drugs Models, Specifications, and Application
Table 61. Bayer Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Bayer Company Profile and Main Business
Table 63. Bayer Recent Developments
Table 64. Almirall Company Information, Head Office, Market Area, and Industry Position
Table 65. Almirall Oral Anti-allergic Drugs Models, Specifications, and Application
Table 66. Almirall Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Almirall Company Profile and Main Business
Table 68. Almirall Recent Developments
Table 69. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 70. Pfizer Oral Anti-allergic Drugs Models, Specifications, and Application
Table 71. Pfizer Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Pfizer Company Profile and Main Business
Table 73. Pfizer Recent Developments
Table 74. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 75. AstraZeneca Oral Anti-allergic Drugs Models, Specifications, and Application
Table 76. AstraZeneca Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. AstraZeneca Company Profile and Main Business
Table 78. AstraZeneca Recent Developments
Table 79. Sun Pharma Company Information, Head Office, Market Area, and Industry Position
Table 80. Sun Pharma Oral Anti-allergic Drugs Models, Specifications, and Application
Table 81. Sun Pharma Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Sun Pharma Company Profile and Main Business
Table 83. Sun Pharma Recent Developments
Table 84. Novartis Company Information, Head Office, Market Area, and Industry Position
Table 85. Novartis Oral Anti-allergic Drugs Models, Specifications, and Application
Table 86. Novartis Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Novartis Company Profile and Main Business
Table 88. Novartis Recent Developments
Table 89. Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
Table 90. Boehringer Ingelheim Oral Anti-allergic Drugs Models, Specifications, and Application
Table 91. Boehringer Ingelheim Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Boehringer Ingelheim Company Profile and Main Business
Table 93. Boehringer Ingelheim Recent Developments
Table 94. UCB Pharma Company Information, Head Office, Market Area, and Industry Position
Table 95. UCB Pharma Oral Anti-allergic Drugs Models, Specifications, and Application
Table 96. UCB Pharma Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. UCB Pharma Company Profile and Main Business
Table 98. UCB Pharma Recent Developments
Table 99. Yangtze River Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position
Table 100. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Models, Specifications, and Application
Table 101. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Yangtze River Pharmaceutical Group Company Profile and Main Business
Table 103. Yangtze River Pharmaceutical Group Recent Developments
Table 104. Hainan Poly Pharm Company Information, Head Office, Market Area, and Industry Position
Table 105. Hainan Poly Pharm Oral Anti-allergic Drugs Models, Specifications, and Application
Table 106. Hainan Poly Pharm Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Hainan Poly Pharm Company Profile and Main Business
Table 108. Hainan Poly Pharm Recent Developments
Table 109. Chongqing Huapont Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 110. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Models, Specifications, and Application
Table 111. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Chongqing Huapont Pharmaceutical Company Profile and Main Business
Table 113. Chongqing Huapont Pharmaceutical Recent Developments
Table 114. Dawnrays Pharma Company Information, Head Office, Market Area, and Industry Position
Table 115. Dawnrays Pharma Oral Anti-allergic Drugs Models, Specifications, and Application
Table 116. Dawnrays Pharma Oral Anti-allergic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Dawnrays Pharma Company Profile and Main Business
Table 118. Dawnrays Pharma Recent Developments
List of Figures
Figure 1. Oral Anti-allergic Drugs Picture
Figure 2. Global Oral Anti-allergic Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Oral Anti-allergic Drugs Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Oral Anti-allergic Drugs Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Oral Anti-allergic Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Oral Anti-allergic Drugs Sales Quantity (K Units) & (2018-2029)
Figure 7. China Oral Anti-allergic Drugs Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Oral Anti-allergic Drugs Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Oral Anti-allergic Drugs Market Share of Global, 2018-2029
Figure 10. Global Oral Anti-allergic Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Oral Anti-allergic Drugs Key Participants, Market Share, 2022
Figure 12. Global Oral Anti-allergic Drugs Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Oral Anti-allergic Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Oral Anti-allergic Drugs Production Market Share & Forecast by Region, 2018-2029
Figure 15. Oral Anti-allergic Drugs Industry Chain
Figure 16. Oral Anti-allergic Drugs Procurement Model
Figure 17. Oral Anti-allergic Drugs Sales Model
Figure 18. Oral Anti-allergic Drugs Sales Channels, Direct Sales, and Distribution
Figure 19. Antihistamine Drugs
Figure 20. Allergic Mediator Release Agent
Figure 21. Immunosuppressant Drugs
Figure 22. By Type, Global Oral Anti-allergic Drugs Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Oral Anti-allergic Drugs Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Oral Anti-allergic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 25. By Type, Global Oral Anti-allergic Drugs Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Oral Anti-allergic Drugs Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. Hospital Pharmacies
Figure 28. Retail Pharmacies
Figure 29. Online Pharmacies
Figure 30. By Application, Global Oral Anti-allergic Drugs Consumption Value, 2018-2029, US$ Million
Figure 31. By Application, Global Oral Anti-allergic Drugs Consumption Value Market Share, 2018-2029
Figure 32. By Application, Global Oral Anti-allergic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 33. By Application, Global Oral Anti-allergic Drugs Sales Quantity Market Share, 2018-2029
Figure 34. By Application, Global Oral Anti-allergic Drugs Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 35. By Region, Global Oral Anti-allergic Drugs Consumption Value Market Share, 2018-2029
Figure 36. By Region, Global Oral Anti-allergic Drugs Sales Quantity Market Share, 2018-2029
Figure 37. North America Oral Anti-allergic Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, North America Oral Anti-allergic Drugs Consumption Value Market Share, 2022
Figure 39. Europe Oral Anti-allergic Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, Europe Oral Anti-allergic Drugs Consumption Value Market Share, 2022
Figure 41. Asia Pacific Oral Anti-allergic Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country/Region, Asia Pacific Oral Anti-allergic Drugs Consumption Value Market Share, 2022
Figure 43. South America Oral Anti-allergic Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, South America Oral Anti-allergic Drugs Consumption Value Market Share, 2022
Figure 45. Middle East & Africa Oral Anti-allergic Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. U.S. Oral Anti-allergic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 47. By Type, U.S. Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 48. By Application, U.S. Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 49. Europe Oral Anti-allergic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 50. By Type, Europe Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 51. By Application, Europe Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 52. China Oral Anti-allergic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 53. By Type, China Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 54. By Application, China Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 55. Japan Oral Anti-allergic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 56. By Type, Japan Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 57. By Application, Japan Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 58. South Korea Oral Anti-allergic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 59. By Type, South Korea Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 60. By Application, South Korea Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 61. Southeast Asia Oral Anti-allergic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 62. By Type, Southeast Asia Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 63. By Application, Southeast Asia Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 64. India Oral Anti-allergic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 65. By Type, India Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 66. By Application, India Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 67. Middle East & Africa Oral Anti-allergic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 68. By Type, Middle East & Africa Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 69. By Application, Middle East & Africa Oral Anti-allergic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 70. Research Methodology
Figure 71. Breakdown of Primary Interviews
Figure 72. Bottom-up and Top-down Approaches
Figure 73. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|